Drug action on poly(A) polymerase activity and isoforms during U937 cell apoptosis

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Poly(A) polymerase (PAP) is crucial for mRNA polyadenylation, with its activity and isoforms varying during the cell cycle and apoptosis.
• Anticancer drugs induce cell damage, triggering apoptosis via signaling pathways.
• Understanding drug mechanisms at the molecular level, like PAP activity, is vital for cancer therapy.

Purpose of the Study:

• To investigate the effect of chemotherapeutic agents, interferon (IFN) and 5-fluorouracil (5-FU), on poly(A) polymerase (PAP) activity and isoforms in U937 cells undergoing apoptosis.
• To explore the relationship between PAP modulation and the induction of apoptosis by these drugs, alone and in combination.

Main Methods:

• U937 cells were treated with IFN and 5-FU, individually and in combination.
• Apoptosis was assessed by observing DNA fragmentation.
• PAP activity was measured, and its isoforms were detected using immunoblotting.

Main Results:

• Both IFN and 5-FU induced apoptosis in U937 cells, evidenced by DNA fragmentation.
• Combined treatment with 5-FU and IFN resulted in partial inactivation and dephosphorylation of PAP.
• PAP activity and isoform changes were observed in parallel with the apoptotic trend.

Conclusions:

• Chemotherapeutic agents, particularly the combination of 5-FU and IFN, impact PAP activity and isoforms during drug-induced apoptosis.
• These findings provide new insights into the mechanism of drug-induced apoptosis and the role of mRNA polyadenylation in this process.
• The study highlights the potential of targeting mRNA polyadenylation pathways in cancer therapy.